総合的なフォローアップケアと高リスク乳児の生命を脅かす疾患: ランダム化制御試験
R S Broyles1, J E Tyson, E T Heyne
1University of Texas-Houston Medical School, 6431 Fannin St, MSB 3. 228, Houston, TX 77030-1503, USA.
JAMA
|October 24, 2000
まとめ
高リスクの乳児に対する総合的なケアにより,生命を脅かす疾患と重症病棟入院が,コストを増やすことなく著しく減少しました. このアプローチは,脆弱な都市部の新生児の健康状態を改善します.
科学分野:
- 小児科は小児科です.
- 医療サービス 研究 医療サービス
- 公衆衛生は公衆衛生である.
背景:
- 都市の中心部で高リスクの乳児は,しばしば分散した保健医療に直面し,深刻な病気のリスクを高めます.
- 一貫した医療へのアクセスの制限は,脆弱な新生児の健康問題を悪化させる可能性があります.
研究 の 目的:
- 総合的なフォローアップケアが,リスクの高い都市部の幼児の生命を脅かす病気を減らすための費用対効果の高い戦略であるかどうかを判断する.
- 医療へのアクセスの改善が重篤な健康障害や医療費に与える影響を評価する.
主な方法:
- 887人の出生体重が非常に低い乳児を対象としたランダム化比較試験です.
- 乳児は,日常のフォローアップケアまたは24時間介護者のアクセスを持つ包括的なケアに割り当てられました.
- 生命を脅かす病気と病院費用は,盲目の評価者によって1歳までの年齢まで評価されました.
主要な成果:
- 総合的なケアにより,生命を脅かす疾患 (48%減少),集中治療院入院 (57%減少),集中治療日 (42%減少) が著しく減少しました.
- 診療所への訪問や電話の増加にもかかわらず,総合医療は乳児一人当たりの総推定費用を増加させませんでした.
- 総合ケア群の乳児は,ルーティンケア群と比較して1年後の未知のアウトカムを示した.
結論:
- 経験豊富な介護者が提供する包括的なフォローアップケアは,リスクの高い市内部の乳児の重症疾患の軽減に効果的です.
- この強化ケアモデルは,追加の医療費を負うことなく,乳児の健康状態を改善します.
- この研究は,都市部の脆弱な幼児集団のための包括的ケアプログラムの実施を支援します.
関連する概念動画
01:30Preventive Healthcare Services
2.4K
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
2.4K
01:22Healthcare Associated Infections II: Preventive Measures
4.7K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
4.7K
01:30Pneumonia III: Complications and Assessment
1.4K
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.4K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
631
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
631
01:29Drug Dosing: Infants and Children
1.0K
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
1.0K
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
413
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
413